U.S. Retail Distributors Stock News

NYSE:STAG
NYSE:STAGIndustrial REITs

Stronger Q4 Results And Higher Dividend Might Change The Case For Investing In STAG Industrial (STAG)

STAG Industrial, Inc. reported past full-year 2025 results showing sales of US$843.01 million, revenue of US$845.18 million, and net income of US$273.52 million, alongside strong Q4 leasing activity, high occupancy of 96.4%, and meaningful property acquisitions. The company’s 6.3% increase in core FFO per share, 4% dividend raise, the largest since 2014, and shift to quarterly payments underscore how heightened leasing, acquisitions, and disciplined balance sheet management are reshaping its...
NYSE:KFY
NYSE:KFYProfessional Services

A Look At Korn Ferry (KFY) Valuation As Quality Metrics Clash With Cost And Market Pressures

Recent analysis of Korn Ferry (KFY) has drawn attention to its strong return on invested capital and profit quality, while also flagging end market pressures and rising expenses that are shaping a more cautious investor mood. See our latest analysis for Korn Ferry. The recent 7 day share price return of 8.09% decline and 30 day share price return of 9.92% decline, alongside a relatively modest 5.90% decline in 1 year total shareholder return and positive 3 and 5 year total shareholder...
NasdaqGS:TW
NasdaqGS:TWCapital Markets

Did Tradeweb’s MAXEX Push and Bigger Buyback Just Shift Tradeweb Markets' (TW) Investment Narrative?

In February 2026, Tradeweb Markets Inc. reported fourth-quarter 2025 revenue of US$521.18 million and net income of US$324.99 million, raised its quarterly dividend to US$0.14 per share, completed a prior share repurchase program, authorized a new US$500 million buyback, and earlier this month announced a commercial collaboration and investment with MAXEX to link its more than 3,000 global clients to MAXEX’s roughly 400 U.S. mortgage lenders and institutional investors. By connecting...
NasdaqGS:FOXA
NasdaqGS:FOXAMedia

Fox Taps Disney Veteran Aragón To Refresh Advertising And Investor Story

Fox (NasdaqGS:FOXA) has appointed Lucas P. Aragón as Senior Vice President, Creative at FOX Advertising. Aragón joins from Disney, bringing experience across major networks including OWN. The hire signals a focus on creative branding and client facing campaigns within Fox's advertising business. For investors tracking Fox at a current share price of $56.35, this leadership move arrives after a mixed return profile, with a 2.3% gain over the past year alongside a 58.4% return over three...
NYSE:DVN
NYSE:DVNOil and Gas

Weaker Earnings And Oil‑to‑Gas Shift Might Change The Case For Investing In Devon Energy (DVN)

Devon Energy recently reported that its February 17, 2026 earnings release showed earnings per share down more than 30% year over year, alongside an 8.52% revenue decline and a shift toward higher gas revenues but lower oil revenues. This combination of weaker earnings and a changing oil-gas revenue mix has prompted analysts to reassess their expectations and trim earnings forecasts. Next, we’ll consider how these weaker near-term earnings expectations and downward estimate revisions affect...
NasdaqGS:ZION
NasdaqGS:ZIONBanks

Is Zions (ZION) Using Its New Senior Notes To Quietly Reposition Interest Rate Risk?

Zions Bancorporation, N.A. recently priced and settled a US$500,000,000 fixed‑to‑floating rate senior notes offering due February 9, 2029, with a 4.483% fixed coupon to February 2028 and a subsequent Compounded SOFR plus 1.055% floating rate. The bank plans to use the proceeds to pay down short‑term borrowings while a receive‑fixed hedge converts the new debt cost to floating, reshaping its interest rate risk profile. We’ll now examine how this US$500,000,000 senior notes issuance and...
NYSE:JPM
NYSE:JPMBanks

Assessing JPMorgan Chase (JPM) Valuation After Recent Share Price Pullback And Long Term Gains

Setting the scene for JPMorgan Chase JPMorgan Chase (JPM) has drawn investor attention recently as its share price, last closing at US$302.55, reflects a mix of short term pullbacks alongside longer term gains in total return. See our latest analysis for JPMorgan Chase. Recent trading has been choppy, with a 7 day share price return of 6.07% decline and a year to date share price return of 7.04% decline. At the same time, the 1 year total shareholder return of 11.63% and 5 year total...
NasdaqCM:GLTO
NasdaqCM:GLTOBiotechs

Galecto (GLTO) Is Up 21.3% After $316 Million Equity Raise and New $150 Million Shelf Registration

Galecto, Inc. recently completed a follow-on public offering of common stock, issuing 16,644,737 shares and raising approximately US$316.3 million before fees, with Jefferies, Leerink Partners, Evercore ISI and Guggenheim Securities acting as joint book-running managers. Alongside this offering, Galecto filed a mixed shelf registration of up to US$150 million, giving the company additional flexibility to issue various securities over time to support its pipeline in blood cancers and fibrotic...
NYSE:VRT
NYSE:VRTElectrical

Is It Too Late To Consider Vertiv (VRT) After Its 117% One Year Surge

If you are wondering whether Vertiv Holdings Co is still attractively priced after its run, you are not alone. The stock has become a regular talking point for valuation focused investors. Vertiv's share price closed at US$234.53, with returns of 16.1% over the past week, 32.6% over the past month and 33.6% year to date. The 1 year gain stands at 117.4%, and the 3 year and 5 year returns are very large in percentage terms. Recent coverage around Vertiv has focused on its role in critical...
NYSE:KVYO
NYSE:KVYOSoftware

Klaviyo’s Enterprise AI Push Reshapes Growth Story And Valuation Debate

Klaviyo (NYSE:KVYO) is expanding rapidly in the enterprise market, with a sharp rise in high-value customers. The company is rolling out advanced AI agents that support more autonomous customer experiences. Doubled million dollar ARR accounts and growing enterprise adoption suggest a meaningful shift in its business mix. Klaviyo, known for its marketing automation and customer data platform tools, is pushing further into larger enterprise accounts as retailers and brands seek more automated...
NasdaqGS:PLMR
NasdaqGS:PLMRInsurance

What Palomar Holdings (PLMR)'s Record 2025 Earnings and Weaker Underwriting Efficiency Mean For Shareholders

In February 2026, Palomar Holdings reported fourth-quarter and full-year 2025 results showing revenue rising to US$253.36 million for the quarter and US$875.97 million for the year, with net income increasing to US$56.17 million and US$197.07 million respectively, alongside higher basic and diluted earnings per share from continuing operations. Despite these record headline figures, investors focused on weaker-than-expected underwriting efficiency, as margin pressures and a higher combined...
NYSE:MPC
NYSE:MPCOil and Gas

Marathon Petroleum (MPC) Valuation After Higher Q4 Net Income And Ongoing Share Buybacks

Fourth quarter results and buybacks in focus Marathon Petroleum (MPC) reported fourth quarter 2025 revenue of US$33,422 million with net income of US$1,535 million, alongside continued share repurchases that reduced the share count during the period. See our latest analysis for Marathon Petroleum. The latest quarterly results and ongoing repurchases appear to have supported sentiment, with a 1-month share price return of 15.73% and a year to date share price return of 23.08%. The 5-year total...
NYSE:CSR
NYSE:CSRResidential REITs

The Bull Case For Centerspace (CSR) Could Change Following Q4 Results Highlighting Leverage Strain - Learn Why

On February 16, 2026, Centerspace released its fourth-quarter results, following earlier expectations for an earnings-per-share improvement and upwardly revised revenue forecasts. The earnings release sharpened focus on the trade-off between improving analyst expectations and ongoing balance sheet pressures, including high leverage and low interest coverage. Now, we'll examine how Centerspace's fourth-quarter earnings expectations amid ongoing leverage concerns may influence the company's...
NasdaqGM:ALVO
NasdaqGM:ALVOBiotechs

Is There Now an Opportunity in Alvotech (ALVO) After a 64% One-Year Share Price Slide?

Wondering whether Alvotech at US$4.64 is a potential bargain or a value trap? This article will walk you through what the current price might be implying about the company. The stock has had a tough run, with a 9.7% decline over the last week, 5.7% over the last month and 7.2% year to date, while the 1 year return sits at a 64.3% loss. Recent trading has been shaped by ongoing investor reaction to Alvotech's progress and risks in the biosimilars space, as the market weighs its prospects...
NYSE:RRX
NYSE:RRXElectrical

The Bull Case For Regal Rexnord (RRX) Could Change Following New 2026 EPS Guidance And 2025 Results

In February 2026, Regal Rexnord reported that fourth-quarter 2025 sales rose to US$1,523.2 million while net income increased to US$63.5 million, with full-year 2025 net income improving to US$279.5 million on slightly lower annual sales of US$5,934.5 million. The company also issued full-year 2026 GAAP diluted EPS guidance of US$5.29 to US$6.09, highlighting management’s confidence after year-over-year earnings growth despite softer annual revenue. With management now guiding 2026 GAAP...
NYSE:PATH
NYSE:PATHSoftware

Is UiPath (PATH) Starting To Look Attractive After Recent Share Price Weakness

If you are wondering whether UiPath is starting to look interesting at current levels, this article will walk through what the recent share price and fundamentals might be telling you about its value. UiPath shares last closed at US$11.32, with returns of 12.9% decline over 7 days, 21.1% decline over 30 days, 28.7% decline year to date, 24.2% decline over 1 year and 27.2% decline over 3 years, which may have shifted how the market is thinking about its risk and potential. Recent headlines...
NYSE:ADT
NYSE:ADTConsumer Services

Assessing ADT (ADT) Valuation After Recent S&P Index Additions

Why ADT’s index additions matter for investors ADT (ADT) has just been added to the S&P 600, S&P 1000, S&P Composite 1500, and the S&P 600 Consumer Discretionary index, a shift that can influence trading interest and liquidity. See our latest analysis for ADT. ADT’s recent index additions come after a period where short term share price returns have been soft, with a 7 day share price return decline of 4.56% and a 30 day share price return decline of 6.18%. Meanwhile, the 1 year total...
NYSE:BSX
NYSE:BSXMedical Equipment

A Look At Boston Scientific (BSX) Valuation As Electrophysiology Concerns Follow Strong Q4 Earnings

Boston Scientific (BSX) is back in focus after Q4 2025 adjusted earnings came in above consensus. However, investor attention has shifted to signs of stagnation in the company’s U.S. electrophysiology business. See our latest analysis for Boston Scientific. The share price has retreated sharply in recent months, with a 30 day share price return of 15.15% and a 90 day share price return of 24.68%, even though the 3 year total shareholder return sits at 60.57% and the 5 year total shareholder...
NasdaqGS:AGIO
NasdaqGS:AGIOBiotechs

Agios’ 2025 Loss, AQVESME Launch, and New Shelf Offering Might Change The Case For Investing In Agios Pharmaceuticals (AGIO)

Agios Pharmaceuticals reported full-year 2025 results, with revenue rising to US$54.03 million from US$36.5 million, while swinging from net income of US$673.73 million to a very large net loss of US$412.78 million and filing an omnibus mixed-shelf registration covering equity, debt, warrants, and units. Despite the sharp earnings reversal, investors are focusing on stronger-than-expected quarterly performance, growing contributions from PYRUKYND® and newly launched AQVESME™, and the added...
NYSE:OXY
NYSE:OXYOil and Gas

Is Occidental Petroleum (OXY) Pricing Reflect Long Term Value After Mixed Multi Year Returns

If you are wondering whether Occidental Petroleum's current share price really reflects its underlying value, you are not alone. This article is designed to help you weigh what you are paying against what you are getting. The stock last closed at US$46.07, with recent returns of a 1.3% decline over 7 days, 7.9% over 30 days, 8.7% year to date, a 2.0% decline over 1 year, a 20.3% decline over 3 years, and 84.7% over 5 years. Taken together, this gives you a mixed picture of how the market has...